Memantine

Primary Uses

Memantine is specifically approved for the treatment of moderate to severe dementia of the Alzheimer's type. It is generally prescribed when symptoms have progressed beyond the mild stage of the disease.

The medication is intended to help patients with:

• Memory and thinking: It may improve the ability to remember information and maintain awareness.
• Daily activities: It can help individuals maintain their ability to perform routine tasks for a longer period.
• Communication: Some patients may experience improved clarity in communication and social interaction.

How It Is Prescribed

Memantine may be used alone or in combination with other medications for Alzheimer's disease, such as cholinesterase inhibitors. It is available in several forms, including immediate-release tablets, extended-release capsules, and an oral solution.

While memantine can help manage the symptoms of dementia, it is important to note that it does not cure Alzheimer's disease. It does not stop the underlying disease process or prevent the eventual progression of symptoms.

Regulating Glutamate

Memantine belongs to a class of medications called NMDA receptor antagonists. It works by managing the activity of glutamate, a neurotransmitter that sends signals between nerve cells. In a healthy brain, glutamate is released in specific amounts to help the brain process, store, and retrieve information.

Protecting Nerve Cells

In people with moderate-to-severe Alzheimer's disease, the brain may produce too much glutamate. When glutamate levels are excessively high, it can overstimulate nerve cells. This constant overstimulation creates background noise that makes it difficult for the brain to process clear signals and can eventually lead to nerve cell damage or death.

Memantine helps by:

• Blocking NMDA receptors to prevent them from being over-activated by excess glutamate.
• Reducing the background noise so that important signals can be detected more easily by the brain.
• Protecting nerve cells from the damage caused by chronic overstimulation.

By stabilizing glutamate activity, memantine may help improve memory, awareness, and the ability to perform daily tasks. It is important to note that while memantine treats the symptoms of Alzheimer's disease, it is not a cure and does not stop the underlying progression of the condition.

Common Side Effects

The most frequently reported side effects of memantine are usually mild and may improve as the body adjusts to the medication. These include:

• Dizziness
• Headache
• Confusion
• Constipation
• Sleepiness or fatigue
• High blood pressure
• Back pain
• Cough
• Vomiting

Serious Side Effects

In some cases, memantine can cause serious health issues that require immediate medical attention. Seek help right away if you experience:

• Allergic reactions: Symptoms such as a severe skin rash, hives, itching, or swelling of the face, lips, tongue, and throat.
• Difficulty breathing: Shortness of breath or wheezing.
• Hallucinations: Seeing or hearing things that are not there.
• Seizures: Uncontrolled body movements or loss of consciousness.
• Severe confusion: A sudden or significant change in mental status beyond typical dementia symptoms.

Urine Alkalinity

Certain factors that increase the alkalinity of urine can slow down the removal of memantine from the body, which may increase the risk of side effects. These factors include:

• Significant changes in diet, such as switching from a high-protein to a vegetarian diet.
• The use of specific medications, including sodium bicarbonate and carbonic anhydrase inhibitors.
• Medical conditions such as renal tubular acidosis or severe urinary tract infections.

Kidney and Liver Impairment

Because the kidneys are the primary route for eliminating memantine, patients with severe renal impairment may need a reduced dosage. There is limited information regarding the use of memantine in patients with severe liver impairment, so caution is advised in these cases.

Seizure Risk

Memantine has not been thoroughly studied in people with a history of seizure disorders. While seizures were reported by a small number of participants during clinical trials, it is not certain if the medication was the cause.

Cardiovascular Conditions

Clinical studies often excluded patients with recent heart attacks, uncontrolled high blood pressure, or uncompensated heart failure. Therefore, healthcare providers may use extra caution when prescribing memantine to individuals with these conditions.

Hypersensitivity

This medication should not be used by anyone who has had a severe allergic reaction to memantine or any of the inactive ingredients in the tablet or oral solution.

Pregnancy

There are no adequate or well-controlled studies on the use of memantine in pregnant women. Animal studies have shown some evidence of developmental toxicity when the drug was administered at doses that also caused toxicity in the mother. Because human data is lacking, memantine should only be used during pregnancy if the potential benefit to the patient outweighs the potential risk to the fetus.

Breastfeeding

It is not known whether memantine passes into human breast milk. Many medications are excreted in breast milk, and the potential for adverse effects in a nursing infant is unknown. Healthcare providers typically advise caution when considering the use of memantine while breastfeeding.

If you are pregnant, planning to become pregnant, or breastfeeding, consult with a healthcare professional to determine the safest course of treatment.

Oral Tablets

Memantine is available as immediate-release tablets. These are typically prescribed to be taken twice per day.

Extended-Release Capsules

Extended-release capsules are formulated to release the medication into the body gradually. This form is usually taken once daily. For individuals who have trouble swallowing, the capsules can be opened and the contents sprinkled onto a small amount of applesauce.

Oral Solution

A liquid oral solution is available for those who prefer or require a liquid format. This form is typically taken twice daily and should be measured using the specific dosing device provided with the medication.

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved memantine for the treatment of moderate to severe dementia of the Alzheimer's type. It is intended to help manage symptoms of the disease but is not a cure for the underlying condition.

Regulatory Status

• Prescription Requirement: Memantine is available only with a prescription from a licensed healthcare provider.
• Boxed Warnings: There are no FDA boxed warnings associated with memantine.
• REMS: The FDA does not require a Risk Evaluation and Mitigation Strategy (REMS) for this medication.

Approved Formulations

The FDA has approved several versions of memantine, including immediate-release tablets, extended-release capsules, and an oral solution. Additionally, a combination product containing both memantine and donepezil is FDA-approved for patients with moderate to severe Alzheimer's disease who are already stabilized on specific doses of both individual medications.

Generic Availability

Memantine is available as a generic medication. Generic versions are typically much less expensive than brand-name products. Because memantine is often used for long-term treatment of Alzheimer's disease, choosing a generic version can result in significant savings over time.

Insurance and Medicare Coverage

Most Medicare Part D plans and private health insurance policies cover memantine, particularly in its generic form. The specific out-of-pocket cost depends on the insurance plan's formulary, the patient's deductible, and the specific copayment or coinsurance requirements.

Factors Affecting Retail Price

Several factors can influence the cost of memantine at the pharmacy:

• Formulation: The price may vary depending on whether the medication is prescribed as an immediate-release tablet, an extended-release capsule, or an oral solution.
• Pharmacy Selection: Prices can differ between retail pharmacies, and some may offer lower prices through mail-order programs.
• Prescription Size: Obtaining a larger supply, such as a 90-day prescription, may reduce the overall cost per dose compared to a 30-day supply.